Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study

Masaki Shiota, Motonobu Nakamura, Akira Yokomizo, Toshihisa Tomoda, Naotaka Sakamoto, Narihito Seki, Shuji Hasegawa, Takakazu Yunoki, Masahiko Harano, Kentaro Kuroiwa, Masatoshi Eto

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds